EXAGEN INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Exagen Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
  • Exagen Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.97M, a 40.8% increase year-over-year.
  • Exagen Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$17.3M, a 50.7% increase year-over-year.
  • Exagen Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$23.7M, a 50% increase from 2022.
  • Exagen Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$47.4M, a 76.5% decline from 2021.
  • Exagen Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$26.9M, a 60.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$17.3M -$2.97M +$2.05M +40.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 -$19.4M -$3.36M +$4.33M +56.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-05
Q4 2023 -$23.7M -$5.57M +$8.78M +61.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 -$32.5M -$5.42M +$2.68M +33.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$35.2M -$5.01M +$9.65M +65.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 -$44.8M -$7.69M +$2.58M +25.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-05
Q4 2022 -$47.4M -$14.4M -$7.3M -104% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$40.1M -$8.1M -$917K -12.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$39.2M -$14.7M -$8.26M -129% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$30.9M -$10.3M -$4.06M -65.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$26.9M -$7.05M -$3.6M -104% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 -$23.3M -$7.18M -$2.87M -66.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$20.4M -$6.41M -$3.05M -90.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-21
Q1 2021 -$17.3M -$6.21M -$646K -11.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-21
Q4 2020 -$16.7M -$3.45M -$45K -1.32% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$16.6M -$4.31M -$1.17M -37.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$15.5M -$3.36M -$578K -20.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$14.9M -$5.56M -$2.86M -106% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$12M -$3.41M -$2.09M -159% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$9.95M -$3.14M -$1.39M -78.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$8.56M -$2.79M -$639K -29.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$7.92M -$2.7M +$89K +3.19% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$8.01M -$1.32M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 -$1.76M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$2.15M Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$2.79M Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.